KIMIA BIOSCIENCES LTD Revenue and Competitors

Delhi, IND

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • KIMIA BIOSCIENCES LTD's estimated annual revenue is currently $15.3M per year.(i)
  • KIMIA BIOSCIENCES LTD's estimated revenue per employee is $100,500

Employee Data

  • KIMIA BIOSCIENCES LTD has 152 Employees.(i)
  • KIMIA BIOSCIENCES LTD grew their employee count by 11% last year.

KIMIA BIOSCIENCES LTD's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$56.6M56321%N/AN/A
#2
$15.6M15528%N/AN/A
#3
$17M169-11%N/AN/A
#4
$13.2M1318%N/AN/A
#5
$19.6M19510%N/AN/A
#6
$23.5M2347%N/AN/A
#7
$5.3M530%N/AN/A
#8
$13M129-25%N/AN/A
#9
$20.5M20411%N/AN/A
#10
$11.7M1166%N/AN/A
Add Company

What Is KIMIA BIOSCIENCES LTD?

KIMIA is engaged in manufacturing of bulk drugs addressing to various high potential therapeutic segments and has envisaged high growth plans through infrastructure creation and CMS. Moving forward towards vertical integration Kimia has plans to set up its own FFF facilities for Life Style segments with international regulatory standards to be able to not only launch itself in ROW but advance markets also. We envision to become an established pharmaceutical company with both in APIs and FDFs globally for having top class marketing practices. KIMIA believes in maintaining the highest level of integrity, transparency and ethics. Ensure efficiency that delivers better experience at a lower cost. KIMIA embraces community values and culture. At KIMIA , maximum emphasis is laid on Quality Assurance of products and procedures. We are committed to offer the best pharmaceutical products to our consumers and healthcare professionals together with unsurpassed marketing support.

keywords:N/A

N/A

Total Funding

152

Number of Employees

$15.3M

Revenue (est)

11%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$21.3M16153%N/A
#2
N/A16325%N/A
#3
$9.3M1668%N/A
#4
N/A16926%N/A
#5
$22.9M17010%N/A